Clopidogrel sulfate is an antiplatelet agent. Specifically, Clopidogrel sulfate inhibits the binding of ADP to its receptors on the membranes of platelet cells, and blocks ADP-mediated activation of the glycoprotein GPIIb/IIIa complex. Clopidogrel sulfate can be used for research of heart disease and stroke.
References:
[1]. Pindelska E, et al. Solid-state NMR as an effective method of polymorphic analysis: solid dosage forms of clopidogrel drogensulfate. J Pharm Sci. 2015 Jan;104(1):106-13.